Two authors assessed the risk of bias for each study through five aspects: random sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting
At that point, you are stuck
The precise contribution of glucagon receptor activation to addiction-related outcomes remains an active area of investigation, with early preclinical work suggesting it may enhance the effects achieved through GLP-1 and GIP alone
Avoid tight clothing that may irritate the area
In the NEJM Phase 2 trial, participants assigned to an initial dose of 4 mg experienced significantly more adverse events than those who started at 2 mg, even when both groups ultimately reached the same target dose
KNOW THIS: If you have a normal T level, TRT is unlikely to make any difference at all